Chun Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Chun Yang has a total of 39 co-authors. Here are the top co-authors by number of shared publications:
- Lei Xu
Department of Pathogenic Biology, School of Basic Medicine, Chongqing Medical University, 1 Medical College Road, Yuzhong District, Chongqing, China, 86 2368485288
2 shared publications Nan Lu
Chongqing Medical University, Chongqing 400016, China
2 shared publicationsBianbian Li
West China School of Public Health, Sichuan University, Chengdu, 610041, PR China
1 shared publicationChencheng Fang
Center for Molecular Medicine and Tumor Research, Department of Pathogen Biology, School of Basic Medicine, Chonqing Medical University, Chongqing 400016, China
1 shared publicationD. M. Zhu
Tuberculosis Reference Laboratory, Chongqing Tuberculosis Control Institute, Chongqing 400050, China
1 shared publication- Dairong Li
Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China
1 shared publication
Latest Publications
- Open Access
- 2 April 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-9
The Mycobacterium tuberculosis CRISPR-Associated Cas1 Involves Persistence and Tolerance to Anti-Tubercular Drugs
Tuberculosis remains one of the leading causes of death worldwide. Even if new antitubercular drugs are currently being developed, the rapid emergence and spread of drug-resistant strain remain a severe challenge. The CRISPR associated proteins 1 (Cas1), a most conserved endonuclease which is responsible for spacer integration into CRISPR arrays, was found deleted in many specific drug-resistant strains. The function of Cas1 is still unknown in Mycobacterium type III-A CRISPR family. In this study, the Cas1 (Rv2817c) defect was found in 57.14% of clinical isolates. To investigate the function of Cas1 in new spacer acquisition, we challenged Bacillus Calmette–Guérin (BCG) with a mycobacteriophage D29. Newly acquired spacer sequence matches D29 genome was not found by spacer deep-sequencing. We further expressed Cas1 in recombinant Mycobacterium smegmatis. We found that Cas1 increased the sensitivity to multiple anti-tuberculosis drugs by reducing the persistence during drug treatment. We also showed that Cas1 impaired the repair of DNA damage and changed the stress response of Mycobacterium smegmatis. This study provides a further understanding of Cas1 in Mycobacterium tuberculosis complex (MTBC) drug-resistance evolution and a new sight for the tuberculosis treatment.
- 2 April 2019
- Published by Wiley in BioMed Research International
- Vol. 2019, 1-9
Open AccessThe Mycobacterium tuberculosis CRISPR-Associated Cas1 Involves Persistence and Tolerance to Anti-Tubercular Drugs
Tuberculosis remains one of the leading causes of death worldwide. Even if new antitubercular drugs are currently being developed, the rapid emergence and spread of drug-resistant strain remain a severe challenge. The CRISPR associated proteins 1 (Cas1), a most conserved endonuclease which is responsible for spacer integration into CRISPR arrays, was found deleted in many specific drug-resistant strains. The function of Cas1 is still unknown in Mycobacterium type III-A CRISPR family. In this study, the Cas1 (Rv2817c) defect was found in 57.14% of clinical isolates. To investigate the function of Cas1 in new spacer acquisition, we challenged Bacillus Calmette–Guérin (BCG) with a mycobacteriophage D29. Newly acquired spacer sequence matches D29 genome was not found by spacer deep-sequencing. We further expressed Cas1 in recombinant Mycobacterium smegmatis. We found that Cas1 increased the sensitivity to multiple anti-tuberculosis drugs by reducing the persistence during drug treatment. We also showed that Cas1 impaired the repair of DNA damage and changed the stress response of Mycobacterium smegmatis. This study provides a further understanding of Cas1 in Mycobacterium tuberculosis complex (MTBC) drug-resistance evolution and a new sight for the tuberculosis treatment.
- 1 February 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 496 (4) , 1076-1081
General misincorporation frequency: Re-evaluation of the fidelity of DNA polymerases
- 1 February 2018
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 496 (4) , 1076-1081
General misincorporation frequency: Re-evaluation of the fidelity of DNA polymerases
- Open Access
- 1 January 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-9
Prevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-ResistantMycobacterium tuberculosisIsolates in Southwest of China
This study aimed to investigate the prevalence of multidrug-resistant tuberculosis (MDR-TB) isolates resistant to the second-line antituberculosis drugs (SLDs) and its association with resistant-related gene mutations inMycobacterium tuberculosis(M.tb) isolates from Southwest of China. There were 81 isolates resistant to at least one of the SLDs among 156 MDR-TB isolates (81/156, 51.9%). The rates of general resistance to each of the drugs were as follows: OFX (66/156, 42.3%), KAN (26/156, 16.7%), CAP (13/156, 8.3%), PTO (11/156, 7.1%), PAS (22/156, 14.1%), and AMK (20/156, 12.8%). Therefore, the most predominant pattern was resistant to OFX compared with other SLDs (). The results of sequencing showed that 80.2% OFX-resistant MDR-TB isolates containedgyrAmutation and 88.5% KAN-resistant isolates hadrrsmutations with the most frequent mutation being A1401G. These results suggest that improper use of SLDs especially OFX is a real threat to effective MDR-TB treatment not only in China but also in the whole world. Furthermore the tuberculosis control agencies should carry out SLDs susceptibility testing and rapid screening in a broader population of TB patients immediately and the SLDs should be strictly regulated by the administration in order to maintain their efficacy to treat MDR-TB.- 1 January 2017
- Published by Wiley in BioMed Research International
- Vol. 2017, 1-9
Open AccessPrevalence and Molecular Characterization of Second-Line Drugs Resistance among Multidrug-ResistantMycobacterium tuberculosisIsolates in Southwest of China
This study aimed to investigate the prevalence of multidrug-resistant tuberculosis (MDR-TB) isolates resistant to the second-line antituberculosis drugs (SLDs) and its association with resistant-related gene mutations inMycobacterium tuberculosis(M.tb) isolates from Southwest of China. There were 81 isolates resistant to at least one of the SLDs among 156 MDR-TB isolates (81/156, 51.9%). The rates of general resistance to each of the drugs were as follows: OFX (66/156, 42.3%), KAN (26/156, 16.7%), CAP (13/156, 8.3%), PTO (11/156, 7.1%), PAS (22/156, 14.1%), and AMK (20/156, 12.8%). Therefore, the most predominant pattern was resistant to OFX compared with other SLDs (). The results of sequencing showed that 80.2% OFX-resistant MDR-TB isolates containedgyrAmutation and 88.5% KAN-resistant isolates hadrrsmutations with the most frequent mutation being A1401G. These results suggest that improper use of SLDs especially OFX is a real threat to effective MDR-TB treatment not only in China but also in the whole world. Furthermore the tuberculosis control agencies should carry out SLDs susceptibility testing and rapid screening in a broader population of TB patients immediately and the SLDs should be strictly regulated by the administration in order to maintain their efficacy to treat MDR-TB. - 1 October 2016
- Vol. 32 (10) , 1317-1320
[Zinc-dependent metalloprotease 1 (Zmp1) inhibits the proliferation and phagosome-lysosome fusion of mouse macrophage RAW264.7].
Objective To observe the effect of zinc-dependent metalloprotease 1 (Zmp1) of Bacillus Calmette Guerin vaccine (BCG) on the proliferation and phagosome-lysosome fusion of RAW264.7 mouse macrophage. Methods Zmp1 was expressed in E.coli BL21 (DE3) and purified by metal chelate magnetic beads. RAW264.7 cells were incubated with the purified Zmp1. Cell proliferation was detected at 0, 24, 48, 72 and 96 hours by cell counting kit-8 (CCK-8) assay and cell cycle distribution was detected by flow cytometry (FCM). The formation of phagosome was induced after RAW264.7 cells were infected with attenuated Salmonella. Attenuated Salmonella in phagosomes and lysosome associated membrane protein 1 (LAMP1) were marked by Alexa FluorR350-anti-Salmonella antibodies (blue fluorescence) and Cy5-anti-LAMP1 antibodies (red fluorescence), respectively. Two kind of fluorescence in RAW264.7 cells were observed under a fluorescent microscope and the fusion of phagosome and lysosome was analyzed by overlaying two kind of fluorescence (purple fluorescence). Results RAW264.7 cell proliferation decreased obviously 48 hours after treated with Zmp1, and the cell count in G1 phase declined, but the number of S-phase cells increased. In RAW264.7 cells infected with attenuated Salmonella and labeled by double immunofluorescent staining, phagolysosomes exhibiting purple fluorescence were reduced after treated by Zmp1. Conclusion Zmp1 can inhibit mouse RAW264.7 cell proliferation and phagosome-lysosome fusion.
- 1 October 2016
- Vol. 32 (10) , 1317-1320
[Zinc-dependent metalloprotease 1 (Zmp1) inhibits the proliferation and phagosome-lysosome fusion of mouse macrophage RAW264.7].
Objective To observe the effect of zinc-dependent metalloprotease 1 (Zmp1) of Bacillus Calmette Guerin vaccine (BCG) on the proliferation and phagosome-lysosome fusion of RAW264.7 mouse macrophage. Methods Zmp1 was expressed in E.coli BL21 (DE3) and purified by metal chelate magnetic beads. RAW264.7 cells were incubated with the purified Zmp1. Cell proliferation was detected at 0, 24, 48, 72 and 96 hours by cell counting kit-8 (CCK-8) assay and cell cycle distribution was detected by flow cytometry (FCM). The formation of phagosome was induced after RAW264.7 cells were infected with attenuated Salmonella. Attenuated Salmonella in phagosomes and lysosome associated membrane protein 1 (LAMP1) were marked by Alexa FluorR350-anti-Salmonella antibodies (blue fluorescence) and Cy5-anti-LAMP1 antibodies (red fluorescence), respectively. Two kind of fluorescence in RAW264.7 cells were observed under a fluorescent microscope and the fusion of phagosome and lysosome was analyzed by overlaying two kind of fluorescence (purple fluorescence). Results RAW264.7 cell proliferation decreased obviously 48 hours after treated with Zmp1, and the cell count in G1 phase declined, but the number of S-phase cells increased. In RAW264.7 cells infected with attenuated Salmonella and labeled by double immunofluorescent staining, phagolysosomes exhibiting purple fluorescence were reduced after treated by Zmp1. Conclusion Zmp1 can inhibit mouse RAW264.7 cell proliferation and phagosome-lysosome fusion.
- 1 May 2014
- Published by Elsevier in Human Immunology
- Vol. 75 (5) , 428-432
Primary application of PPE68 of Mycobacterium tuberculosis
- 1 May 2014
- Published by Elsevier in Human Immunology
- Vol. 75 (5) , 428-432
Primary application of PPE68 of Mycobacterium tuberculosis